Evaluation and Management of Dyslipidemia in Patients with HIV Infection
Green ML. Evaluation and Management of Dyslipidemia in Patients with HIV Infection. Journal Of General Internal Medicine 2002, 17: 797-810. PMID: 12390557, PMCID: PMC1495116, DOI: 10.1046/j.1525-1497.2002.20201.x.Peer-Reviewed Original ResearchMeSH KeywordsAntiretroviral Therapy, Highly ActiveHIV InfectionsHumansHyperlipidemiasHypolipidemic AgentsConceptsHIV infectionMetabolic abnormalitiesAntiretroviral therapyLipid abnormalitiesInsulin resistanceSevere hypertriglyceridemiaMultiple potential drug interactionsLong-term cardiovascular riskLow-density lipoprotein cholesterolCoronary heart disease riskNon-nucleoside reverse transcriptase inhibitorFrank diabetes mellitusPI-naïve patientsActive antiretroviral therapyCD4 lymphocyte countHIV infection statusHIV viral loadLipid-lowering medicationsManagement of dyslipidemiaElevated total cholesterolHeart disease riskPotential drug interactionsTreatment of dyslipidemiaReverse transcriptase inhibitorSame metabolic abnormality